“We have demonstrated, in a … study, that administering low-dose interleukin-2 (IL-2) and … retinoic acid ( RA ), there was a significant improvement of the immune function, with low toxicity, in PTS with advanced … had been treated with aggressive surgery and chemotherapy (Clin Cancer Res 7: 1251-1257, 2001).”